New MenB vaccine to be introduced into the UK routine schedule
The JCVI (Joint Committee on Vaccination and Immunisation) has today recommended that a vaccine against group B meningococcus (MenB) should become part of the NHS’s routine immunisation schedule for children, as long as the Department of Health can negotiate a cost-effective price with the manufacturer. The vaccine will be given at 2, 4 and 12 months. See more information about the new MenB vaccine.